Ankylosing spondylitis (AS) and gout are common inflammatory arthropathies. It had been claimed previously that the two conditions rarely coexist. The aim of this study was to compare the prevalence of gout in a population of AS patients to its prevalence in the general population. To conduct this population-based case–control study, data of adult patients with a physician diagnosis of AS were retrieved from the database of the largest health-care provider organization in Israel, Clalit Health Services. For each patient with AS, five age- and sex-matched subjects without AS were randomly selected from the same database. Different parameters including the existence of gout, hypertension, body mass index, socioeconomic status, and smoking were evaluated in both the AS and the control groups. The study included 3763 patients with AS and 19,214 controls. The proportion of gout in the AS group was higher than in the control group: 73 subjects in the AS group had gout, while only 107 subjects in the non-AS group had gout (1.94% and 0.56%, respectively, OR 3.53, P < 0.001). Logistic regression adjusting for possible confounding variables found that AS was independently associated with gout (OR 1.41, P = 0.037). Our study suggests that gout is not less common in AS patients in comparison with the general population, and that it might even be more common in AS patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Non-steroidal anti-inflammatory drugs
Clalit Health Services
Body mass index
Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374:2563–2574. https://doi.org/10.1056/NEJMra1406182
Smith JA (2014) Update on ankylosing spondylitis: current concepts in pathogenesis. Curr Allergy Asthma Rep 15:489. https://doi.org/10.1007/s11882-014-0489-6
Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66. https://doi.org/10.1007/s00296-002-0237-4
Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379–1390. https://doi.org/10.1016/S0140-6736(07)60635-7
Kuo C-F, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649–662. https://doi.org/10.1038/nrrheum.2015.91
Zlnay D, Rovensky J, Bosak V, Zlnay M (2004) The coincidence of ankylosing spondylitis and gouty arthritis. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 10:47–50. https://doi.org/10.1097/01.rhu.0000111306.55417.19
Yildiz N, Sutbeyaz ST, Koseoglu F (2011) Coexisting ankylosing spondylitis and gouty arthritis/Ankilozan spondilit ve gut artriti birlikteligi. Turk J Phys Med Rehabil 57:111–114. https://doi.org/10.4274/tftr.57.23
Wong DM, Chalmers IM (1994) Coexistent acute gouty arthritis and ankylosing spondylitis. A rare occurrence. J Rheumatol 21:773–774
Duda J, Rovensky J, Tauchmannova H, Bakosova J (2005) Coincidence of ankylosing spondylitis, gouty arthritis and chondrocalcinosis articularis. Isr Med Assoc J IMAJ 7:679
Ho H-H, Yu K-H, Chen J-Y, Lin J-L, Wu Y-JJ, Luo S-F, Liou L-B (2007) Coexisting ankylosing spondylitis and gouty arthritis. Clin Rheumatol 26:1655–1661. https://doi.org/10.1007/s10067-007-0563-8
Merdler-Rabinowicz R, Tiosano S, Comaneshter D, Cohen AD, Amital H (2017) Comorbidity of gout and rheumatoid arthritis in a large population database. Clin Rheumatol 36:657–660. https://doi.org/10.1007/s10067-016-3477-5
Houri Levi E, Watad A, Whitby A, Tiosano S, Comaneshter D, Cohen AD, Amital H (2016) Coexistence of ischemic heart disease and rheumatoid arthritis patients—a case control study. Autoimmun Rev 15:393–396. https://doi.org/10.1016/j.autrev.2016.01.006
Bieber V, Cohen AD, Freud T, Agmon-Levin N, Gertel S, Amital H (2013) Autoimmune smoke and fire-coexisting rheumatoid arthritis and chronic obstructive pulmonary disease: a cross-sectional analysis. Immunol Res 56:261–266. https://doi.org/10.1007/s12026-013-8395-x
Dahan S, Shor DB-A, Comaneshter D, Tekes-Manova D, Shovman O, Amital H, Cohen AD (2016) All disease begins in the gut: celiac disease co-existence with SLE. Autoimmun Rev 15:848–853. https://doi.org/10.1016/j.autrev.2016.06.003
Watad A, Cohen AD, Comaneshter D, Tekes-Manova D, Amital H (2016) Hyperthyroidism association with SLE, lessons from real-life data—a case–control study. Autoimmunity 49:17–20. https://doi.org/10.3109/08916934.2015.1090985
MacFarlane LA, Kim SC (2014) Gout: a review of non-modifiable and modifiable risk factors. Rheum Dis Clin N Am 40:581–604. https://doi.org/10.1016/2Fj.rdc.2014.07.002
Schlesinger N (2014) Treatment of acute gout. Rheum Dis Clin N Am 40:329–341. https://doi.org/10.1016/j.rdc.2014.01.008
Bajaj S, Fessler BJ, Alarcon GS (2004) Systemic lupus erythematosus and gouty arthritis: an uncommon association. Rheumatology 43:349–352. https://doi.org/10.1093/rheumatology/keh043
Merola JF, Wu S, Han J, Choi HK, Qureshi AA (2015) Psoriasis, psoriatic arthritis, and risk of gout in US men and women. Ann Rheum Dis 74:1495–1500. https://doi.org/10.1136/annrheumdis-2014-205212
Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M (2016) Comorbidities in patients with gout prior to and following diagnosis: case–control study. Ann Rheum Dis [Internet]. https://doi.org/10.1136/annrheumdis-2014-206410
Howard RG, Samuels J, Gyftopoulos S, Krasnokutsky S, Leung J, Swearingen CJ, Pillinger MH (2015) Presence of gout is associated with increased prevalence and severity of knee osteoarthritis: among older men: results of a pilot study. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 21:63–71. https://doi.org/10.1097/RHU.0000000000000217
Roddy E, Doherty M (2012) Gout and osteoarthritis: a pathogenetic link? Jt Bone Spine 79:425–427. https://doi.org/10.1016/j.jbspin.2012.03.013
MacDonald AG, Downham C, Jones GT, Macfarlane GJ, Dean LE, Sturrock RD (2013) Global prevalence of ankylosing spondylitis. Rheumatology 53:650–657. https://doi.org/10.1093/rheumatology/ket387
Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G (2006) High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 26:710. https://doi.org/10.1007/s10067-006-0380-5
Puig JG, Martínez MA (2008) Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 20:187. https://doi.org/10.1097/BOR.0b013e3282f4b1ed
Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165:742–748. https://doi.org/10.1001/archinte.165.7.742
Thottam GE, Krasnokutsky S, Pillinger MH (2017) Gout and metabolic syndrome: a tangled web. Curr Rheumatol Rep 19(10):60. https://doi.org/10.1007/s11926-017-0688-y
Ahmed N, Prior JA, Chen Y, Hayward R, Mallen CD, Hider SL (2016) Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study. Clin Rheumatol 35:3069–3073. https://doi.org/10.1007/s10067-016-3362-2
Yi YS (2018) Role of inflammasomes in inflammatory autoimmune rheumatic diseases. Korean J Physiol Pharmacol 22(1):1–15. https://doi.org/10.4196/kjpp.2018.22.1.1
Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241. https://doi.org/10.1038/nature04516
Conflict of interest
Relationships relevant to this manuscript within the last 3 years: Prof. Arnon Cohen received research grants from Janssen, Novartis, AbbVie, Janssen, and Sanofi. Prof. Arnon Cohen served as a consultant, advisor, or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Samsung Bioepis, Sanofi, Sirbal, and Taro. All other authors declare no conflict of interest.
The study fulfilled the ethical guidelines of the most recent Declaration of Helsinki and received approval by the local ethical committee of the Clalit Health Services on 27/08/18. The protocol number for this study was 0212-17-COM.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
There were no related congress abstract publications with regard to this study.
About this article
Cite this article
Gonen, T., Tiosano, S., Comaneshter, D. et al. The coexistence of gout in ankylosing spondylitis patients: a case control study. Rheumatol Int 40, 465–470 (2020). https://doi.org/10.1007/s00296-019-04462-x
- Ankylosing spondylitis
- Case–control study
- Rheumatic diseases